2,6-Dimethoxybenzaldehyde → 6-(2,6-dimethoxyphenyl)-1-((1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)methyl)piperidin-2-one
Reaction equation
[CH3:1][N:2]1[C:6]2[CH:7]=[CH:8][C:9]([CH2:11][NH2:12])=[CH:10][C:5]=2[N:4]=[N:3]1.[CH3:13][O:14][C:15]1[CH:22]=[CH:21][CH:20]=[C:19]([O:23][CH3:24])[C:16]=1[CH:17]=O>>[CH3:13][O:14][C:15]1[CH:22]=[CH:21][CH:20]=[C:19]([O:23][CH3:24])[C:16]=1[CH:17]1[N:12]([CH2:11][C:9]2[CH:8]=[CH:7][C:6]3[N:2]([CH3:1])[N:3]=[N:4][C:5]=3[CH:10]=2)[C:15](=[O:14])[CH2:16][CH2:19][CH2:20]1Participants
3
Procedure
Prepared according to the described general procedure 6 (GP6) with commercially available (1-methyl-1H-benzo[d][1,2,3]triazol-5-yl)methanamine and commercially available 2,6-dimethoxybenzaldehyde. Subsequent purification by preparative HPLC afforded the target compound. LC-MS (conditions E): tR=0.65 min.; [M+H]+: 381.09 g/mol.
Workup
- customPrepared
- customSubsequent purification by preparative HPLC
- customafforded the target compound
Sources & evidence
- ORD record
- ord-b59890ace319484fa4eae81eebbfca35
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09242970B2
Reaction notes
Loading…